Cargando…

Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture

BACKGROUND: At present, the design of an ideal placebo control in acupuncture studies challenges researchers. Previously devised sham acupuncture techniques have reported various imperfections; therefore, the specific effects of acupuncture cannot be accurately examined in clinical trials primarily...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Wenke, Wang, Hui, Zhang, Li, Bian, Zhaoxiang, Shang, Hongcai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816100/
https://www.ncbi.nlm.nih.gov/pubmed/24168427
http://dx.doi.org/10.1186/1745-6215-14-359
_version_ 1782289493630386176
author Zheng, Wenke
Wang, Hui
Zhang, Li
Bian, Zhaoxiang
Shang, Hongcai
author_facet Zheng, Wenke
Wang, Hui
Zhang, Li
Bian, Zhaoxiang
Shang, Hongcai
author_sort Zheng, Wenke
collection PubMed
description BACKGROUND: At present, the design of an ideal placebo control in acupuncture studies challenges researchers. Previously devised sham acupuncture techniques have reported various imperfections; therefore, the specific effects of acupuncture cannot be accurately examined in clinical trials primarily because of interferences from the placebo effects. METHOD: Guided by evidence-based medicine (EBM) theories, we have made an initial attempt to establish a set of control methods for use in acupuncture studies, which is named the target disease-guided placebo-controlled (TIGER) design. In a trial using the TIGER design, participants suffering simultaneously from a predefined target disease and a pseudo target disease will be recruited and randomized to receive identical acupuncture intervention measures. As a result, the interventions not only appear the same but also produce the same stimulations in both groups. The patients in the treatment group will be informed of the actual target disease that the treatment aims for, whereas patients in the control group will be informed that the treatment is for the pseudotarget disease. It is speculated that no psychological response will be aroused in the control group. During data analysis, changes in the outcome measures of the patients in the control groupreveal the real therapeutic effect of acupuncture, and those of patients in the treatment group show both the real and placebo acupuncture effect. In this article, we explain how to put this design into use in a planned randomized clinical trial of acupuncture for the treatment of migraine. RESULTS: This approach can eliminate the acupuncture placebo effect in the control group that may confound trial results. It is possible to observe the specific and placebo effects of acupuncture for the target disease separately using the TIGER design. CONCLUSIONS: The proposed TIGER design has limitations. It is designed for clinical studies focusing on the specific effects of acupuncture, and it needs to be tested and verified for practicality and feasibility in various clinical research settings.
format Online
Article
Text
id pubmed-3816100
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38161002013-11-04 Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture Zheng, Wenke Wang, Hui Zhang, Li Bian, Zhaoxiang Shang, Hongcai Trials Methodology BACKGROUND: At present, the design of an ideal placebo control in acupuncture studies challenges researchers. Previously devised sham acupuncture techniques have reported various imperfections; therefore, the specific effects of acupuncture cannot be accurately examined in clinical trials primarily because of interferences from the placebo effects. METHOD: Guided by evidence-based medicine (EBM) theories, we have made an initial attempt to establish a set of control methods for use in acupuncture studies, which is named the target disease-guided placebo-controlled (TIGER) design. In a trial using the TIGER design, participants suffering simultaneously from a predefined target disease and a pseudo target disease will be recruited and randomized to receive identical acupuncture intervention measures. As a result, the interventions not only appear the same but also produce the same stimulations in both groups. The patients in the treatment group will be informed of the actual target disease that the treatment aims for, whereas patients in the control group will be informed that the treatment is for the pseudotarget disease. It is speculated that no psychological response will be aroused in the control group. During data analysis, changes in the outcome measures of the patients in the control groupreveal the real therapeutic effect of acupuncture, and those of patients in the treatment group show both the real and placebo acupuncture effect. In this article, we explain how to put this design into use in a planned randomized clinical trial of acupuncture for the treatment of migraine. RESULTS: This approach can eliminate the acupuncture placebo effect in the control group that may confound trial results. It is possible to observe the specific and placebo effects of acupuncture for the target disease separately using the TIGER design. CONCLUSIONS: The proposed TIGER design has limitations. It is designed for clinical studies focusing on the specific effects of acupuncture, and it needs to be tested and verified for practicality and feasibility in various clinical research settings. BioMed Central 2013-10-29 /pmc/articles/PMC3816100/ /pubmed/24168427 http://dx.doi.org/10.1186/1745-6215-14-359 Text en Copyright © 2013 Zheng et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Zheng, Wenke
Wang, Hui
Zhang, Li
Bian, Zhaoxiang
Shang, Hongcai
Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture
title Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture
title_full Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture
title_fullStr Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture
title_full_unstemmed Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture
title_short Target dIsease-Guided placEbo-contRolled (TIGER) design: a novel method for clinical trials of acupuncture
title_sort target disease-guided placebo-controlled (tiger) design: a novel method for clinical trials of acupuncture
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816100/
https://www.ncbi.nlm.nih.gov/pubmed/24168427
http://dx.doi.org/10.1186/1745-6215-14-359
work_keys_str_mv AT zhengwenke targetdiseaseguidedplacebocontrolledtigerdesignanovelmethodforclinicaltrialsofacupuncture
AT wanghui targetdiseaseguidedplacebocontrolledtigerdesignanovelmethodforclinicaltrialsofacupuncture
AT zhangli targetdiseaseguidedplacebocontrolledtigerdesignanovelmethodforclinicaltrialsofacupuncture
AT bianzhaoxiang targetdiseaseguidedplacebocontrolledtigerdesignanovelmethodforclinicaltrialsofacupuncture
AT shanghongcai targetdiseaseguidedplacebocontrolledtigerdesignanovelmethodforclinicaltrialsofacupuncture